Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 02, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; ...

Hutchmed receives China NMPA conditional approval for Orpathys to treat gastric cancer patients with MET amplification: Hong Kong, Shanghai Saturday, July 4, 2026, 11:00 Hrs [IST] ...

The next chapter of online casinos' development will likely focus on even deeper integration between gaming and advanced technology ...

The 6.7 Luna VIII Update for Genshin Impact has arrived, and brings with it the conclusion of the Nod-Krai cycle prior to the ...